A Win For Trxade Group, Inc.
Trxade Group, Inc. (MEDS:NASDAQ) rocketted at $14.22, a gain of 27.3%. On Mon, Jul 01, 2024, MEDS:NASDAQ touched a New 2-Week High of $14.22. The stock got featured on our News Catalysts scanner on Thu, Jun 27, 2024 at 09:40 AM in the 'MISCELLANEOUS' category. From Mon, Jun 17, 2024, the stock recorded 55.56% Up Days and 50.00% Green Days
About Trxade Group, Inc. (MEDS:NASDAQ)
Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.
Top 10 Gainers:
- Senti Biosciences Inc Com (SNTI:NASDAQ), 51.27%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Ocean Power Technologies Inc. (OPTT:NYSEMKT), 41.06%
- Presto Automation Inc Com (PRST:NASDAQ), 39.14%
- TROOPS Inc. (TROO:NASDAQ), 36.04%
- POET Technologies Inc. (POET:NASDAQ), 33.82%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 33.45%
- Complete Solaria Inc. (CSLR:NASDAQ), 32.14%
- Trxade Group, Inc. (MEDS:NASDAQ), 27.31%